OUTLOOK Historical Income Statement
| OTLK Stock | USD 5.03 0.10 1.95% |
Historical analysis of OUTLOOK THERAPEUTICS income statement accounts such as Total Revenue of 0.0 can show how well OUTLOOK THERAPEUTICS INC performed in making a profits. Evaluating OUTLOOK THERAPEUTICS income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of OUTLOOK THERAPEUTICS's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining OUTLOOK THERAPEUTICS INC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OUTLOOK THERAPEUTICS INC is a good buy for the upcoming year.
OUTLOOK |
About OUTLOOK Income Statement Analysis
OUTLOOK THERAPEUTICS INC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to OUTLOOK THERAPEUTICS shareholders. The income statement also shows OUTLOOK investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
OUTLOOK THERAPEUTICS Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of OUTLOOK THERAPEUTICS INC. It is also known as OUTLOOK THERAPEUTICS overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on OUTLOOK THERAPEUTICS INC income statement and represents the costs associated with goods and services OUTLOOK THERAPEUTICS provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from OUTLOOK THERAPEUTICS's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into OUTLOOK THERAPEUTICS INC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, OUTLOOK THERAPEUTICS's Interest Expense is quite stable compared to the past year. Research Development is expected to rise to about 31.5 M this year, although the value of Gross Profit is projected to rise to (37.8 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.5M | 1.6M | 1.4M | 1.9M | Depreciation And Amortization | 204.7K | 44.2K | 39.8K | 37.8K |
OUTLOOK THERAPEUTICS income statement Correlations
Click cells to compare fundamentals
OUTLOOK THERAPEUTICS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OUTLOOK THERAPEUTICS income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 554.1K | 262.1K | 204.7K | 44.2K | 39.8K | 37.8K | |
| Interest Expense | 1.8M | 936K | 1.5M | 1.6M | 1.4M | 1.9M | |
| Selling General Administrative | 10.0M | 12.8M | 20.7M | 26.7M | 30.7M | 16.7M | |
| Gross Profit | (554.1K) | (262.1K) | (204.7K) | (44.2K) | (39.8K) | (37.8K) | |
| Other Operating Expenses | 36.3M | 51.7M | 63.1M | 53.1M | 61.1M | 47.6M | |
| Operating Income | (36.8M) | (51.7M) | (63.1M) | (53.1M) | (47.8M) | (50.2M) | |
| Net Income From Continuing Ops | (35.2M) | (53.2M) | (66.1M) | (59.0M) | (53.1M) | (55.7M) | |
| Ebit | (36.3M) | (51.7M) | (63.1M) | (57.4M) | (51.7M) | (54.3M) | |
| Research Development | 26.3M | 39.0M | 42.3M | 26.5M | 30.4M | 31.5M | |
| Ebitda | (35.8M) | (51.5M) | (62.9M) | (57.4M) | (51.6M) | (54.2M) | |
| Cost Of Revenue | 554.1K | 262.1K | 204.7K | 44.2K | 50.8K | 48.3K | |
| Total Operating Expenses | 36.3M | 51.7M | 63.1M | 53.1M | 61.1M | 46.6M | |
| Income Before Tax | (38.5M) | (53.2M) | (66.0M) | (59.0M) | (53.1M) | (55.7M) | |
| Total Other Income Expense Net | (1.7M) | (1.4M) | (3.0M) | (5.9M) | (5.3M) | (5.0M) | |
| Net Income Applicable To Common Shares | (36.0M) | (48.9M) | (53.2M) | (66.1M) | (59.4M) | (62.4M) | |
| Net Income | (35.2M) | (53.2M) | (66.1M) | (59.0M) | (53.1M) | (55.7M) | |
| Income Tax Expense | (3.4M) | (3.3M) | 2K | 2.8K | 2.5K | 2.6K | |
| Tax Provision | (3.3M) | 2K | 2.8K | 3K | 2.7K | 2.8K | |
| Net Interest Income | (1.8M) | (936.1K) | (1.5M) | (1.6M) | (1.8M) | (1.9M) | |
| Selling And Marketing Expenses | 7.3M | 3.8M | 1.9M | 279.7K | 251.7K | 239.1K | |
| Reconciled Depreciation | 554.1K | 262.1K | 204.7K | 44.2K | 39.8K | 37.8K | |
| Non Operating Income Net Other | 1.8M | (1.7M) | (498.5K) | (608.4K) | (547.5K) | (520.1K) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.89) | Revenue Per Share 0.119 | Quarterly Revenue Growth 6.583 | Return On Assets (0.84) | Return On Equity (0.04) |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.